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Reduction-oxidation or “redox” reactions are an integral part of a broad range of cellular
processes such as gene expression, energy metabolism, protein import and folding, and
autophagy. As many of these processes are intimately linked with cell fate decisions,
transient or chronic changes in cellular redox equilibrium are likely to contribute to the
initiation and progression of a plethora of human diseases. Since a long time, it is known
that mitochondria are major players in redox regulation and signaling. More recently,
it has become clear that also peroxisomes have the capacity to impact redox-linked
physiological processes. To serve this function, peroxisomes cooperate with other
organelles, including mitochondria. This review provides a comprehensive picture of what
is currently known about the redox interplay between mitochondria and peroxisomes
in mammals. We first outline the pro- and antioxidant systems of both organelles and
how they may function as redox signaling nodes. Next, we critically review and discuss
emerging evidence that peroxisomes and mitochondria share an intricate redox-sensitive
relationship and cooperate in cell fate decisions. Key issues include possible physiological
roles, messengers, and mechanisms. We also provide examples of how data mining
of publicly-available datasets from “omics” technologies can be a powerful means to
gain additional insights into potential redox signaling pathways between peroxisomes
and mitochondria. Finally, we highlight the need for more studies that seek to clarify
the mechanisms of how mitochondria may act as dynamic receivers, integrators, and
transmitters of peroxisome-derived mediators of oxidative stress. The outcome of
such studies may open up exciting new avenues for the community of researchers
working on cellular responses to organelle-derived oxidative stress, a research field
in which the role of peroxisomes is currently highly underestimated and an issue of
discussion.
Keywords: antioxidant systems, interorganellar cross-talk, mitochondria, oxidative stress, peroxisomes,
pro-oxidant systems, redox signaling
Abbreviations: ACOX, acyl-CoA oxidase; ARA, arachidonic acid; DHA, docosahexaenoic acid; EPHX, epoxide hydrolase;
ETC, electron transport chain; 4-HNE, 4-hydroxy-2-nonenal; GLRX, glutaredoxin; GPX, glutathione peroxidase; GSH,
reduced glutathione; GSR, oxidized glutathione reductase; GSSG, oxidized glutathione; MAM, mitochondria-associated
membrane; MDA, malondialdehyde; mPTP, mitochondrial permeability transition pore; NOS, nitric oxide synthase; NOX,
NADPH oxidase; OXPHOS, oxidative phosphorylation; PUFA, polyunsaturated fatty acid; PRDX, peroxiredoxin; RCC,
respiratory chain complex; RIRR, ROS-induced ROS release; RNS, reactive nitrogen species; ROS, reactive oxygen species;
SOD, superoxide dismutase; TRX, thioredoxin; TSC, tuberous sclerosis complex; TXNRD, thioredoxin reductase; VLCFA,
very-long-chain fatty acid; X-ALD, X-linked adrenoleukodystrophy; XDH, xanthine dehydrogenase.
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Introduction
All life on earth is powered by reduction-oxidation (redox)
reactions, in which electrons are transferred from a donor to an
acceptor molecule. To survive, cells had to evolve mechanisms
to control redox potential intervals in which biological processes
and signaling pathways can take place (Foyer and Noctor,
2011). To cope with this challenge, cells have developed spatially
compartmentalized redox circuits that are regulated by various
small molecule- and protein-based redox buffer systems (Forman
et al., 2010; Mallikarjun et al., 2012). As organisms need to
sense and respond to changing environmental conditions, these
circuits have to be sufficiently flexible to (locally) respond
to exogenous stimuli and endogenous metabolic alterations.
Shifts in the intracellular redox equilibrium may favor either
beneficial or detrimental outcomes (Figure 1). The outcomes
are determined by a combination of factors, including the types
of oxidants produced, their concentration and localization, and
their kinetics of production and elimination (Trachootham et al.,
2008; Forman et al., 2010). A shift of the redox equilibrium in
favor of oxidized biomolecules gives rise to a phenomenon called
“oxidative stress.” High levels of oxidative stress are capable of
causing damage to all major biomolecules and of initiating cell
death (Jones and Go, 2010). However, low levels of oxidative
stress may promote cell proliferation and survival pathways
(Holmström and Finkel, 2014). As such, it is not surprising to
see that changes in the cellular redox environment significantly
contribute to the development of virtually all major chronic
human disorders, including atherosclerosis, cancer, diabetes, and
neurodegeneration (Groitl and Jakob, 2014; Holmström and
Finkel, 2014).
Redox signaling refers to the concept that electron-transfer
processes play a key messenger role in biological systems (Rigas
and Sun, 2008; Burgoyne et al., 2012). Cells produce two different
FIGURE 1 | ROS/RNS, antioxidants, and cellular redox balance in
health and disease.
types of redox signaling molecules: the first type comprises
reactive oxygen species (ROS), such as the superoxide anion
radical (O•−2 ), hydrogen peroxide (H2O2), and the hydroxyl
radical (•OH); the second type covers reactive nitrogen species
(RNS), such as the nitric oxide radical (•NO), the nitrogen
dioxide radical (•NO2), nitrite (NO
−
2 ), and peroxynitrite
(ONOO−) (Nathan and Ding, 2010). Oxidative modifications of
specific target molecules by various ROS/RNS are covalent but
often reversible. The best studied reversible oxidation reactions
include those of H2O2 with sulfhydryl groups (RSH) to yield
disulfides (RSSR’), sulfenic acids (RSOH), or sulfinic acids
(RSO2H), and of •NO with RSH to yield S-nitrosothiols (RSNO)
(Nathan and Ding, 2010). Irreversible oxidation products most
frequently include hydroxylations, carbonylations, nitrations, the
formation of sulfonic acids (RSO3H), and the destruction of iron-
sulfur (FeS) clusters (Nathan and Ding, 2010). As both protein
cysteine thiols and lipids are among the most prominent targets
of ROS/RNS (Trachootham et al., 2008; Hekimi et al., 2011),
many biologically-relevant redox signals are conveyed through
cysteine oxidation and lipid peroxidation. Here, it is of particular
importance to be aware that (i) many signaling components
like kinases, phosphatases, transcription factors, caspases, and
metalloproteases contain active site- or zinc finger-coordinating
cysteines that can be reversibly modified in a redox-responsive
manner (Forman et al., 2010; Corcoran and Cotter, 2013;
Berridge, 2014), and (ii) multiple lipid peroxidation products
[e.g., malondialdehyde (MDA) and 4-hydroxy-2-nonenal (4-
HNE)] can act as important messengers in signaling events
that lead to cell proliferation, differentiation, senescence, or
apoptosis (Fritz and Petersen, 2013; Ayala et al., 2014). Finally, to
counteract oxidative stress, cells are also equipped with various
antioxidant defense systems. These systems can be classified
into two broad categories: the enzymatic antioxidants [e.g.,
superoxide dismutases (SODs), catalase, glutathione peroxidases
and reductases, peroxiredoxins, etc.) and the low molecular
weight antioxidants [e.g., reduced glutathione (GSH), ascorbate
(vitamine C), α-tocopherol (vitamin E), etc.] (Nathan and Ding,
2010).
Major sites of cellular ROS/RNS production include
mitochondria, peroxisomes, the endoplasmic reticulum (ER),
and the NADPH oxidases (NOXs) and nitric oxide synthases
(NOSs) that are located in distinct subcellular locations
(Trachootham et al., 2008; Fransen et al., 2012). In the following
two sections, we will review the pro- and antioxidant systems of
mitochondria and peroxisomes, with a focus on the situation in
mammals. For a detailed description of the other systems, the
reader is referred to other reviews (Bedard and Krause, 2007;
Appenzeller-Herzog, 2011; Förstermann and Sessa, 2012).
The Redox Metabolism of Mitochondria
Pro-oxidant Systems
Mitochondria are key players in cellular redox metabolism.
Important sources of mitochondrial ROS include (i) complex I
and complex III of the electron transport chain (ETC) in the inner
mitochondrial membrane, (ii) dihydrolipoamide dehydrogenase
(DLD), a common subunit of the α-ketoglutarate dehydrogenase
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and pyruvate dehydrogenase multi-enzyme complexes, in the
mitochondrial matrix (Andreyev et al., 2005; Circu and Aw,
2010), and (iii) monoamine oxidase, a mitochondrial outer
membrane-resident flavoprotein (Andreyev et al., 2005; Orrenius
et al., 2007). Monoamine oxidase is an important source of
H2O2 (Orrenius et al., 2007). Complex I, complex III, and
dihydrolipoamide dehydrogenase contain redox centers that are
potentially capable of O•−2 production (Andreyev et al., 2005).
Importantly, while complex I can only produce O•−2 in the
mitochondrial matrix, complex III can release this radical on
both sides of the mitochondrial inner membrane (Orrenius
et al., 2007). Excessive production of O•−2 may not only lead
to the SOD-catalyzed formation of H2O2, but also cause the
release of Fe2+ from FeS-containing proteins (e.g., complex I,
aconitase) (Dixon and Stockwell, 2014). These events may in
turn give rise to •OH via the non-enzymatic Haber-Weiss and
Fenton reactions (Winterbourn, 1995) and initiate a cascade of
reactions resulting in the formation of carbon-centered lipid
radicals (L•), lipid peroxide radicals (LOO•), and multiple lipid
peroxidation products such as MDA and 4-HNE (Ayala et al.,
2014). The role of mitochondria in cellular RNS production
is less well documented. However, here it is worthwhile to
mention that themitochondrial innermembrane contains at least
three NO•-producing enzymes: a posttranslationally modified
splice variant of neuronal NOS (NOS1α), called mitochondrial
NOS (mtNOS) (Ghafourifar and Richter, 1997; Aguirre et al.,
2012); and two molybdopterin-containing amidoxime-reducing
enzymes, called MARC1 and MARC2 (Sparacino-Watkins et al.,
2014). Wheareas, in general, NOSs oxidize L-arginine with O2
to form citrulline and •NO, molybdopterin enzymes have the
capacity to reduce NO−2 to
•NO (Sparacino-Watkins et al., 2014).
Antioxidant Systems
Mitochondria also contain a network of enzymatic and non-
enzymatic antioxidants that protect the organelle from oxidative
damage. The main antioxidant enzymes include thioredoxin 2
(TRX2), thioredoxin reductase (TXNRD2), the glutaredoxins 2
(GLRX2) and 5 (GLRX5), the peroxiredoxins 3 (PRDX3) and
5 (PRDX5), GSH peroxidase 1 (GPX1), oxidized glutathione
(GSSG) reductase (GSR), and the copper/zinc (SOD1)- and
manganese (SOD2)-containing SODs (Kalinina et al., 2008). The
major non-enzymatic antioxidants are GSH, coenzyme A (CoA-
SH; for more details, see The RedoxMetabolism of Peroxisomes -
Antioxidant Systems), ubiquinol (Maroz et al., 2009), vitamin C,
and vitamin E (Sagun et al., 2005; Marí et al., 2009; Lauridsen
and Jensen, 2012). Vitamin E, a fat-soluble nutrient, is present
in relatively low concentrations in mitochondria, and its main
function is to trap LOO•, thereby preventing the propagation
of lipid peroxidation (Forkink et al., 2010). GSH and vitamin C,
two hydrophilic antioxidants, can directly recycle vitamin E to its
reduced active form. GSH is the most important low molecular
weight thiol (∼1-6µmol/g tissue), and its concentration in
mitochondria is estimated at∼10–14mM, similar to the cytosolic
levels. GSH can also directly neutralize •OH and function as
a cofactor of GPX1 to scavenge H2O2 and lipid peroxides
(LOOH) (Forkink et al., 2010). The regeneration of GSH from
GSSG is carried out by GSR, an NADPH-consuming enzyme.
Note that, as GSH is only synthesized de novo in the cytosol,
mitochondria have to import this molecule across their inner
membrane (Marí et al., 2009). An alternative mechanism to
convert mitochondrial H2O2 to H2O involves the oxidation of
PRDX3 or PRDX5. The oxidized forms of these peroxiredoxins
are subsequently reduced by TRX2, which in turn is regenerated
by TXNRD2, an NADPH-dependent FAD-containing enzyme
(Forkink et al., 2010). Two comments should be added at
this point. First, the GSH/GPX/GLRX and PRDX/TRX/TXNRD
redox pathways are considered to be the most important redox
regulating systems in mitochondria (Murphy, 2012). Second, as
(i) GSR and TXNRD2 receive their reducing equivalents from the
mitochondrial NADPH pool, and (ii) the pool of NADPH is kept
reduced by the tricarboxylic acid (TCA) enzymes nicotinamide
nucleotide transhydrogenase (NNT), malic enzyme 3 (ME3), and
isocitrate dehydrogenase 2 (IDH2), it is clear that a functional
TCA cycle is essential for the regeneration of the antioxidant
capacity of the mitochondrial matrix (Kohlhaas and Maack,
2013).
Metabolic Factors Affecting ROS Production
The net release of ROS from mitochondria strongly depends on
the (patho) physiological state of the cell. For example, according
to the classical concept, the rate of ROS production from the ETC
increases when substrates (e.g., glucose, fatty acids) are available,
but energy consumption is low (Kohlhaas and Maack, 2013).
Indeed, when TCA-derived high-energy electron carriers NADH
and FADH2 donate more electrons to the ETC andmitochondria
are not making ATP, the ETC is highly reduced and electrons are
more likely to slip to O2 to produce O
•−
2 (Kohlhaas and Maack,
2013). In addition, also stress situations causing impairment and
uncoupling of specific respiratory chain complexes (RCCs) may
provoke the formation of free radicals (Schönfeld and Wojtczak,
2008; Marí et al., 2009).
The Redox Metabolism of Peroxisomes
Pro-oxidant Systems
As peroxisomes contain large sets of pro- and antioxidant
enzymes, also these organelles have the potential to play a
significant role in cellular redox metabolism and signaling.
The most abundant class of ROS-producing enzymes inside
peroxisomes are the flavin-containing oxidases, which reduce
O2 to H2O2 [for a detailed overview of these enzymes, the
reader is referred to (Antonenkov et al., 2010)]. Depending
on the organism, the tissue and cell type, and the cellular
environment, peroxisomes also contain two potential sources
of O•−2 and
•NO production: xanthine dehydrogenase (XDH)
and the inducible form of NOS (NOS2) (Angermüller et al.,
1987; Stolz et al., 2002; Loughran et al., 2013). XDH is a
key enzyme in the purine degradation pathway that catalyzes
the conversion of hypoxanthine to xanthine and of xanthine
to uric acid, a potent antioxidant and free radical scavenger
(Nishino et al., 2008). However, a select set of posttranslational
modifications (e.g., sulfhydryl oxidation, proteolytic processing)
can rapidly convert the NAD+-dependent dehydrogenase form
of the enzyme to an oxidase form that catalyzes the reduction
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of O2 to O
•−
2 (Nishino et al., 2008). As XDH, like MARC1 and
MARC2 (see The Redox metabolism of Mitochondria - Pro-
oxidant Systems), is a molybdopterin-containing enzyme, it can
also reduce nitrates and NO−2 to NO
• (Harrison, 2002). NOS2 is
a homodimeric heme-containing enzyme that normally catalyzes
the oxidation of L-arginine to NO• and citrulline in a complex
reaction requiring O2, NADPH, tetrahydrobiopterin (BH4),
FMN, and FAD (Del Río, 2011). However, in the absence of
substrate or in its monomeric form, the enzyme can also produce
significant amounts of O•−2 (Stuehr et al., 2001). Interestingly, the
peroxisomal pool of NOS2 appears to be monomeric (Loughran
et al., 2005). Finally, as (i) NO• may rapidly combine with O•−2
to form ONOO− (Pacher et al., 2007), (ii) within the heme
protein-rich environment of peroxisomes, H2O2 may give rise to
•OH through the Fenton reaction (Loughran et al., 2005), and
(iii) •OH is one of the prime catalysts for the initiation of lipid
peroxidation (Ayala et al., 2014), it is very likely that peroxisomes
also function as potential sources of ONOO−, •OH, L•, LOO•,
MDA, and 4-HNE (Ayala et al., 2014).
Antioxidant Systems
Like mitochondria, peroxisomes are also well equipped with
multiple enzymatic and non-enzymatic antioxidant defense
systems that scavenge harmful H2O2 and free radicals, thereby
protecting the organelle from oxidative stress. The best
characterized peroxisomal antioxidant enzyme is catalase, a
heme-containing enzyme that can remove H2O2 in a catalatic
(2 H2O2 → 2 H2O + O2) and peroxidatic (H2O2 + AH2 →
A + 2 H2O) manner (Kirkman and Gaetani, 2007). Typical
peroxidatic electron donors (AH2) are low molecular weight
alcohols, formate, nitrite, and formaldehyde (Kirkman and
Gaetani, 2007). Other antioxidant enzymes include SOD1,
PRDX5, glutathione transferase kappa (GSTK1), “microsomal”
glutathione S-transferase 1 (MGST1), and epoxide hydrolase 2
(EPHX2). As already mentioned above, SOD1 can convert O•−2
to O2 and H2O2 (see The Redox metabolism of Mitochondria -
Pro-oxidant Systems), and PRDX5 can reduce H2O2 to H2O (see
The Redox metabolism of Mitochondria - Antioxidant Systems).
PRDX5 can, in addition, also reduce alkyl hydroperoxides
(ROOH) to their respective alcohols, and ONOO− to NO−2
(Knoops et al., 2011). GSTK1 and MGST1 are thought to play a
role in LOOH detoxification processes (Antonenkov et al., 2010;
Johansson et al., 2010; Wang et al., 2013b), EPHX2 can convert
epoxides to the corresponding dihydrodiols (Decker et al., 2009),
and peroxisomal PRDX5 has recently been shown to exert
a cytoprotective function against H2O2- and LOOH-induced
oxidative stress (Walbrecq et al., 2015). For a detailed description
of these enzymes, the reader is referred to other reviews
(Antonenkov et al., 2010; Fransen et al., 2012). Interestingly,
there is some indirect evidence that also GSH and vitamin C
may play a role in the regulation of the peroxisomal redox state.
Indeed, as the peroxisomal membrane contains a nonselective
pore-forming protein (PXMP2) with an upper molecular size
limit of 300-600 Da (Rokka et al., 2009), these low molecular
weight antioxidants can most likely freely diffuse through the
peroxisomal membrane. The observations that (i) a peroxisomal
variant of roGFP2, a genetically-encoded redox sensor that
specifically equilibrates with the GSSG/GSH redox pair, quickly
responds to redox changes in the peroxisomal matrix, and (ii)
supplementation of vitamin C to the cell culture medium causes
an increase in the intraperoxisomal redox state, are in line
with this hypothesis (Ivashchenko et al., 2011). However, the
precise mechanisms underlying the latter, rather unexpected
observation remain to be unraveled. Nevertheless, in the context
of this review, it is tempting to speculate that, in a heme-rich
environment such as the peroxisomal matrix, vitamin C can
reduce Fe3+ to Fe2+, and that this further drives the generation
of free radicals through the Fenton reaction. Note also that it is
not yet clear how GSSG (molar mass, 612.63 g mol−1) can be
reduced in or exported out of the peroxisomal matrix. Here it
is important to point out that, in contrast to mitochondria (see
The Redox metabolism of Mitochondria - Antioxidant Systems),
peroxisomal thioredoxins and glutaredoxins have not yet been
identified inmammals. Finally, it should be noted that—although
peroxisomes contain (i) enzymes that can produce and consume
NAD(P)+ and NAD(P)H (Visser et al., 2007), and (ii) shuttle
systems that permit the transfer of reducing equivalents without
physical exchange of these redox cofactors between the lumen of
the organelle and the cytoplasm (Rottensteiner and Theodoulou,
2006; Antonenkov et al., 2010; Schueren et al., 2014)—it is
also not yet clear how changes in peroxisomal NAD(P)+ and
NAD(P)H metabolism influence the intra- and extraperoxisomal
redox state.
Metabolic Factors Affecting ROS Production
So far, no consensus has been reached about whether
peroxisomes function as a net source or sink of ROS/RNS
(Fransen et al., 2013). However, as for mitochondria, this most
likely depends on the (patho) physiological state and growth
environment of the cell. This idea is in line with the observation
that the intraperoxisomal redox state is strongly influenced by
various genetic and environmental factors (Ivashchenko et al.,
2011). In the following subsections, we further discuss how
peroxisomal metabolism of fatty acids, acyl-CoA esters, and
plasmalogens may impact on cellular redox state alterations.
Not unexpectedly, most of these lipids are linked to two of the
major metabolic pathways in peroxisomes: β-oxidation and
plasmalogen synthesis.
Fatty Acids and acyl-CoA esters
Mammalian genomes code for at least three functional
peroxisomal acyl-CoA oxidases (ACOX1, ACOX2, ACOX3), and
evidence exists for a fourth gene (ACOXL) (Van Veldhoven,
2010). Additionally, the ACOX1 gene gives rise to two transcripts
via alternative splicing, and this splicing is conserved in
eukaryotes (Morais et al., 2007). Through these different ACOXs,
combined with an uptake mechanism for CoA-esters that
is not controlled and restricted by a carnitine-acylcarnitine
translocase as in mitochondria (Rubio-Gozalbo et al., 2004),
peroxisomes can β-oxidize a broad range of carboxylates,
including medium-, long-, and very-long-chain fatty acids,
mono- and polyunsaturated fatty acids, pristanic acid and other
2-methyl-branched fatty acids, as well as carboxylates with a
bulky or rigid ω-end such as prostanoids, bile acid intermediates
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and xenobiotics, either with or without an α-methyl group
(Van Veldhoven, 2010). Moreover, these organelles can degrade
carboxylates containing a 3-methyl or 2-hydroxy group via
α-oxidation (Van Veldhoven, 2010), whereby the one-carbon
shortened products can be passed onto the β-oxidation system.
Exposure of cells to carboxylates (or their precursors) that are
desaturated by these ACOXs will generate peroxisomal H2O2.
This has been shown in different systems [e.g., cells, perfused
organs (Foerster et al., 1981; Handler and Thurman, 1987),
and intact animals (Van den Branden et al., 1984)] and with
different types of carboxylates [e.g., medium-chain fatty acids
(Skorin et al., 1992); long-chain saturated and mono- and
polyunsaturated fatty acids (Mannaerts et al., 1979; Foerster
et al., 1981; Chu et al., 1995; Okamoto et al., 1997)]; medium-
chain dicarboxylic acids (Leighton et al., 1989); and xenobiotics
such as N-(α-methylbenzyl)azelaamic acid (Yamada et al., 1986;
Suzuki et al., 1990), ω-phenyl-substituted fatty acids (Yamada
et al., 1987), and PCA16, a metabolite of the cytosine arabinoside
antileukemic prodrug YNKO (containing a stearic acid side
chain) (Yoshida et al., 1990).
The amount of H2O2 produced depends strongly on the chain
length of the fatty acids. For example, when comparing fatty
acids ranging from C8:0 to C18:0 in isolated rat hepatocytes,
a maximal activity is observed around C10:0-C12:0 (Yamada
et al., 1987; Suzuki et al., 1990; Skorin et al., 1992). Similarly, ω-
phenyldodecanoic acid (Yamada et al., 1987) and dodecanedioic
acid (Leighton et al., 1989) are optimal compared to their analogs.
Finally, monounsaturated oleic acid is a better H2O2-source
than palmitic acid in rat hepatocytes (Mannaerts et al., 1979)
and perfused rat liver (Foerster et al., 1981). In mice, starvation
increases the H2O2 production by liver, likely due to increased
fatty acid plasma levels (Van den Branden et al., 1984). However,
in cardiac tissue there is no change (Kerckaert and Roels, 1986).
Treatment with fibrates increases the rate of H2O2 production in
hepatocytes (Mannaerts et al., 1979; Foerster et al., 1981; Yamada
et al., 1987; Leighton et al., 1989; Yoshida et al., 1990).
For various fatty acids linked to peroxisomal metabolism, an
influence on ROS levels has been reported. Examples include
(i) phytanic acid (3,7,11,15-tetramethylhexadecanoic acid), a
dietary fatty acid that is degraded via peroxisomal α-oxidation,
(ii) pristanic acid (2,6,10,14-tetramethylpentadecanoic acid), the
breakdown product of phytanic acid, that is degraded via β-
oxidation, (iii) polyunsaturated fatty acids (PUFAs) that are
produced via the retroconversion pathway, and (iv) VLCFAs
that are shortened via β-oxidation (Van Veldhoven, 2010).
Interestingly, long-chain fatty acids that are normally degraded
by mitochondria have been shown to be toxic to insulin-
producing cells (e.g., RINm5F, INS-1E, and primary rat islet
cells), due to the combined effect of increased peroxisomal H2O2
generation and the intrinsically low activity of catalase in these
cells (Gehrmann et al., 2010).
Plasmalogens
An important class of ROS-protecting lipids are plasmalogens.
This class of phospholipids contains a vinyl ether bond at position
one of the glycerol moiety. The initial steps of their biosynthesis
are confined to peroxisomes: glyceronephosphate O-
acyltransferase (GNPAT) acylates dihydroxyacetone-phosphate,
while alkylglycerone-phosphate synthase (AGPS) replaces the
acylgroup by a fatty alcohol (Braverman and Moser, 2012).
Subsequently, the 2-oxogroup is reduced by 1-alkylglycerone-
phosphate reductase (DHRS7B), an enzyme found in the
membrane of both peroxisomes and the ER (Keller et al.,
2009; Lodhi et al., 2012), thereby generating 1-alkylglycero-3-
phosphate which will undergo further metabolic conversions
in the ER, similar to those of 1-acylglycero-3-phosphate [the
precursor of esterglycero(phospho)lipids]. Finally, the double
bond adjacent to the ether bond is introduced in the ER (Nagan
and Zoeller, 2001). At the sn-2 position, plasmalogens are
generally enriched in PUFAs. In some tissues (e.g., brain, testis,
and heart), a substantial portion (10–30%) of the phospholipids
(especially the ethanolamine-phospholipids) are plasmalogens.
The absence of plasmalogens causes a very specific phenotype
in man, described as rhizomelic chondrodysplasia punctata
(dwarfism, shortening of proximal limbs, etc.), but how these
symptoms are linked to plasmalogens is not clear (Braverman
and Moser, 2012).
The vinyl-ether bond makes plasmalogens sensitive to attack
by different ROS-species, both in vitro and in cellulo. Hence,
one can consider them as (lipophilic) antioxidants (Lessig and
Fuchs, 2009), often comparable to tocopherol with regard to
potency. In vitro, plasmalogens delay the oxidative degradation
of PUFAs as good as vitamin E (Engelmann et al., 1994; Reiss
et al., 1997; Hahnel et al., 1999a), most likely due to the
fact that the vinyl-ether bond can scavenge peroxy radicals
and oxidized PUFA products. As this bond can complex
with Cu2+, plasmalogens also attenuate Cu2+-induced lipid
oxidation (Hahnel et al., 1999b). Depending on the type
of oxidative stress, different metabolites can be formed. For
example, while UV light-induced oxidation of plasmalogens
generates aldehydes via dioxetane intermediates, Fe2+/ascorbate
treatment results in the formation of α-hydroxy-aldehydes
via plasmalogen epoxides (Stadelmann-Ingrand et al., 2001).
Plasmalogens do protect cells against chemical hypoxia induced
by antimycin A or cyanide (by scavenging produced ROS),
as shown in the murine monocyte/macrophage cell line RAW
264.7 (Zoeller et al., 1999) and human pulmonary arterial
endothelial cells (PAEC) (Zoeller et al., 2002). During UV-
exposure of Chinese hamster ovary (CHO) cells photosensitized
with ω-pyrene-substituted fatty acids or Merocyanine 540,
plasmalogens disappear (Zoeller et al., 1988). This is most
likely due to the fact that singlet oxygen converts the vinyl-
ether bond into a dioxetane intermediate that subsequently
decomposes into a 2-lysophospholipid, formic acid, and an n-
1 aldehyde (Zoeller et al., 1988). Another ROS-molecule that is
scavenged by plasmalogens is hypochlorous acid (HOCl). This
reactive chlorinating species is produced by myeloperoxidase
and promotes the selective cleavage of plasmalogens into 1-
lysophosphatidylcholine and 2-chloro-fatty aldehydes. This has
been shown in vitro (Albert et al., 2001; Messner et al., 2006; Skaff
et al., 2008; Ullen et al., 2010), in activated neutrophils (Thukkani
et al., 2002) and monocytes (Thukkani et al., 2003), and in mouse
brain with lipopolysacharide-induced neuroinflammation (Ullen
et al., 2010). Likewise, 2-bromo-fatty aldehydes are produced
by stimulated neutrophils (Albert et al., 2002) or eosinophils
(Albert et al., 2003). Note that 2-halo-fatty aldehydes, being
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chemoattractants for phagocytes and stimulators of expression
of phagocyte tethering proteins in endothelial cells, sustain the
inflammatory response. Finally, in thyroid cells, plasmalogens
are susceptible to iodine attack. This results in the formation of
2-iodo-fatty aldehydes (Panneels et al., 1996), a major thyroid
iodolipid that—similar to iodide—regulates thyroid metabolism.
Cells with higher plasmalogen levels are more resistant to
H2O2, hyperoxia, and the O
•−
2 generator plumbagin (Zoeller
et al., 2002), whereas the protective actions are gone in cells
lacking plasmalogens. Photosensitisized plasmalogen-deficient
CHO cells and mouse embryonic fibroblasts are hypersensitive
to light treatment (Zoeller et al., 1988; Wang et al., 2013b),
and plasmalogen-deficient RAW 264.7 cells are more sensitive
to electron transport inhibitors (Zoeller et al., 1999). However,
plasmalogens are apparently not important to protect cells
against lactic acid-induced oxidative stress, at least not in primary
rat astrocytes (Fauconneau et al., 2001).
To conclude this subsection, it should be noted that
plasmalogen-derived oxidation products, and especially 2-
hydroxy-fatty aldehydes (Liu and Sayre, 2003; Stadelmann-
Ingrand et al., 2004) and 2-halo-fatty aldehydes (Stadelmann-
Ingrand et al., 2004; Wildsmith et al., 2006), are reactive
molecules that can modify amino groups of lipids and proteins
(via Schiff base formation) as well as sulfhydryl groups in
proteins. This probably contributes to their short half-life
in cerebral cortex homogenates (Stadelmann-Ingrand et al.,
2001). In addition, oxidation of 2-chloro-fatty aldehydes to 2-
chloro-fatty acids leads to increased ROS, ER-stress, and finally
apoptosis in activated primary humanmonocytes, THP-1 human
monocytes, and RAW 264.7 mouse macrophages (Wang et al.,
2013a). Together with the observations that (i) α-hydroxy fatty
aldehydes and plasmalogen epoxides accumulate in aged brain
and chronic disorders (Lessig and Fuchs, 2009), and (ii) 2-
chloroaldehyde levels are elevated in atherosclerotic plaques and
infarcted rat myocardium (Ford, 2010), these findings question
the scavenger role of plasmalogens. However, it might be that
the pathways degrading these oxidative metabolites are less active
under these conditions.
Mitochondria as Redox Signaling Nodes
Currently, it is widely accepted that redox signals to and from
mitochondria are at the core of a wide variety of biological
processes, including cell proliferation and differentiation,
adaptation to hypoxia, autophagy, immune function, and
hormone signaling (Figure 2) (Collins et al., 2012; Chandel,
2014). The most studied and best characterized mitochondrial
redox signaling molecule is H2O2, which is relatively stable
in vivo and can pass easily through mitochondrial membranes
(Bienert et al., 2006). For example, it has been shown that,
under physiological hypoxia, mitochondrial H2O2 can stabilize
hypoxia-inducible factor 1α (HIF-1α), a transcription factor
playing a key role in the cellular adaptation to oxygen availability
(Chandel et al., 1998). In addition, also other transcription
factors (e.g., FOXO3A, NF-kB, p53, and PGC-1α) and signaling
components (e.g., c-Jun N-terminal kinase, protein tyrosine
phosphatases, cysteine protease Atg4, the mitochondrial
peroxiredoxins, the NLRP3 inflammasome, etc.) have been
identified as targets of mitochondrial H2O2 (Chandel et al.,
2000a,b; Nemoto et al., 2000; Valle et al., 2005; Scherz-Shouval
et al., 2007; Chiribau et al., 2008; Cox et al., 2010; Zhou
et al., 2011; Chae et al., 2013; Frijhoff et al., 2014; Long et al.,
2014; Marinho et al., 2014). However, although it is well
known that H2O2 can selectively modify proteins containing
cysteine residues with a low pKa (Veal et al., 2007), the precise
mechanisms by which mitochondria-derived H2O2 coordinates
or relays (retrograde) signaling events thereby provoking
adaptive or maladaptive responses are not yet entirely clear
(Forkink et al., 2010). Two main models have been proposed:
(i) in the redox relay model, H2O2 scavenging enzymes are first
oxidized and subsequently transfer the oxidative equivalents
to other target proteins (Toledano et al., 2004); and (ii) in
the floodgate model, scavenging enzymes act as molecular
floodgates, keeping H2O2 away from susceptible targets under
basal conditions, but permitting signaling events to occur at
H2O2 thresholds sufficient to inactivate the scavenging enzymes
(Wood et al., 2003).
Another important class of redox signaling molecules are
cardiolipins, which are virtually exclusively localized in the
inner mitochondrial membrane (Ren et al., 2014). Most
cardiolipin species have four unsaturated acyl chains that are
oxidation-sensitive. Currently, it is well documented that—upon
mitochondrial injury and depolarization—a significant portion
of these lipids is externalized to the mitochondrial surface
where they function as an “eat-me”-signal for the autophagic
machinery (Chu et al., 2013). In addition, detailed studies have
established that cardiolipin peroxidation is a critical first step
in cytochrome c release and apoptosis (Kagan et al., 2014).
The precise mechanisms through which peroxidized cardiolipin
species fulfill their action remain to be established, but most likely
they facilitate outer mitochondrial membrane permeabilization
(Kagan et al., 2014; Raemy and Martinou, 2014).
Over the years, it has become clear that mitochondria are
central integrators and transducers for ROS signals from other
cellular sources (Sena and Chandel, 2012). In this context, it is
interesting to briefly discuss the concept of ROS-induced ROS
release (RIRR), a phenomenon wherein mitochondria respond
to elevated ROS concentrations by increasing their own ROS
production (Zorov et al., 2000). RIRR is a mechanism for ROS
amplification and regional ROS generation. The process involves
the opening of two different channels in the mitochondrial
inner membrane: the mitochondrial permeability transition pore
(mPTP) and the inner membrane anion channel (IMAC) (Aon
et al., 2009; Zorov et al., 2014). Opening of the pores (e.g., upon
elevated Ca2+ or ROS levels) may, among other responses [e.g.,
a dissipation of the mitochondrial inner membrane potential
(19m), a ceased production of ATP, etc.], elicit ROS bursts.
Depending on the extent of pore opening and how fast ROS
released from mitochondria are eliminated by intracellular
antioxidant systems, RIRR may (i) constitute an adaptive
housekeeping mechanism to release accumulated toxic levels of
mitochondrial ROS, (ii) activate pools of redox-sensitive proteins
in the vicinity of mitochondria, (iii) trigger RIRR in neighboring
mitochondria, and (iv) lead to the destruction of mitochondria,
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FIGURE 2 | Peroxisomes and mitochondria actively contribute to transcompartmental redox signaling.
and—if propagated from mitochondrion to mitochondrion—of
the cell itself (Zinkevich andGutterman, 2011; Zorov et al., 2014).
Peroxisomes as Redox Signaling Nodes
Although it is already known for years that peroxisomal
metabolism and cellular redox equilibrium are closely
intertwined (Reddy and Rao, 1987), peroxisomes have long
been underestimated and largely ignored as potential redox
signaling platforms. However, a limited but growing number
of studies lend strong support to the idea that these organelles
do actively contribute to transcompartmental ROS signaling
in mammalian cells (Figure 2). For example, alterations in
peroxisomal H2O2 metabolism have been shown to influence the
cellular protein disulfide content (Yang et al., 2007; Ivashchenko
et al., 2011), NF-kB activation (Li et al., 2000; Han et al., 2014),
E-cadherin expression (Han et al., 2014), the secretion of matrix
metalloproteinases (Koepke et al., 2008; Han et al., 2014),
mTORC1 activity and autophagy (Zhang et al., 2013), neuronal
activity (Diano et al., 2011), and cell fate decisions in response to
different stressors (Carter et al., 2004; Chen et al., 2004; Elsner
et al., 2011). Unfortunately, the precise molecular mechanisms
underlying most of these observations remain poorly understood
and sometimes even controversial. For example, although these
and other observations strongly indicate that H2O2 can rapidly
cross the peroxisomal membrane (Boveris et al., 1972; Fritz
et al., 2007), the molecular identity of the channels involved
remains to be determined. In addition, virtually nothing is
known about how peroxisome-derived H2O2 can coordinate or
relay signaling events. In this context, it is important to highlight
and briefly discuss one of the potentially most significant recent
breakthroughs in this research area. It concerns the discovery
that the tuberous sclerosis complex (TSC) signaling node (TSC1,
TSC2, TBC1D7, and Rheb) can localize to peroxisomes, and
that this localization is essential to regulate mTORC1 activity in
response to (peroxisomal) ROS (Zhang et al., 2013). However,
as (i) the peroxisomal localization of TSC2 could not yet be
confirmed by others (Menon et al., 2014), and (ii) peroxisome
proliferator-activated receptor (PPAR) agonist-induced ROS
production and exogenous H2O2 addition do not faithfully
mimic the spatial and temporal signaling pattern of peroxisome-
derived H2O2 [e.g., PPAR agonists increase ROS production
by both peroxisomal and non-peroxisomal enzymes (Pyper
et al., 2010)], these findings should be interpreted with care
and warrant future research. In the context of this section,
it is also worth mentioning that, albeit the intraperoxisomal
redox status is strongly influenced by environmental growth
conditions, peroxisomes resist—within limits—oxidative stress
generated elsewhere in the cell (Ivashchenko et al., 2011).
However, as an increase in the redox state of the cytosol reduces
the import efficiency of peroxisomal matrix proteins (Legakis
et al., 2002; Apanasets et al., 2014), it is very likely that conditions
chronically disturbing the redox state of the cytosol will affect
peroxisome function. Finally, as alterations in peroxisomal ROS
production rapidly trigger changes in the mitochondrial balance
(Ivashchenko et al., 2011), these organelles may act as upstream
initiators of mitochondrial ROS signaling pathways (for more
details, see next section).
To which extent peroxisomal β-oxidation influences the
cellular or mitochondrial redox state under physiological
conditions is not documented. What is interesting to note here
is that African green monkey kidney cells (CV-1 cells) (Chu
et al., 1995), mouse fibroblasts (LM-tk cells) (Dadras et al., 1998),
and rat urothelial cells (MYP3 cells) (Okamoto et al., 1997)
overexpressing rat ACOX1 are transformed upon long-term
culturing in the presence of fatty acids such as linoleic acid, erucic
acid, or nervonic acid. Given that CV-1 cells overexpressing urate
oxidase undergo a similar transformation upon exposure to uric
acid (Chu et al., 1996), H2O2 – and not an acyl-CoA – is thought
to be the causative factor. However, in the intact animal, the
supply of fatty acids to cells will be a limiting factor. For example,
in control rats, hepatic H2O2 production increases when plasma
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fatty acids levels are higher (Van den Branden et al., 1984).
Nevertheless, under basal conditions, hepatic H2O2 production
is comparable in rats and deer mice with or without peroxisome
proliferation (and hence altered ACOX1 levels) (Handler et al.,
1992).
Clearly, when discussing peroxisomal β-oxidation and ROS,
only H2O2 production is emphasized. However, one should recall
that this pathway (as well as any other pathway requiring an
activated carboxylate) acts on acyl-CoAs, and not on free fatty
acids. Most reviews on the role of the thiol/disulfide redox state
in biological systems completely neglect CoA-SH as possible
modulator of ROS-mediated signaling events (Hansen et al.,
2009). Nevertheless, levels of free CoA-SH are substantial (∼10–
150 nmol/g tissue), being highest in liver. The majority of this
cofactor is confined to the mitochondrial matrix, reaching mM
concentrations [e.g., depending on the diet and nutritional status,
it was estimated at 3.5–8.5mM in rat liver (Van Broekhoven
et al., 1981; Horie et al., 1986)]. The cytosolic levels are lower,
ranging from 0.02 to 0.20mM (Van Broekhoven et al., 1981;
Horie et al., 1986). This indicates that CoA-SH is second in
range to glutathione as the most prominent non-protein thiol
in mitochondria (for more details, see Antioxidant Systems).
Moreover, cellular CoA-SH concentration drops upon treatment
with t-butylhydroperoxide and, based on the presence of mixed
CoA-glutathione disulfides and their increase during H2O2
metabolism in perfused rat liver, an interplay between these two
thiol compounds exists (Crane et al., 1982). Finally, the level
of this cofactor is regulated by complex metabolic pathways,
involving more than 25 acyl-CoA synthetases (Watkins et al.,
2007), 13 acyl-CoA thioesterases, and 30 acyltransferases, either
N-acyltransferases (conjugating enzymes) or O-acyltransferases
(acyl-carnitine transferases and other acyltransferases) (Hunt
et al., 2005; searches in the HGNC database of human gene
names). Hence, addition of β-oxidizable peroxisomal substrates
does not only lead to H2O2 production, but also to a lowering
of cellular (cytosolic) CoA-SH. When the CoA-ester is poorly
or not degradable, CoA-SH levels can drop significantly. This
phenomenon, also described as “CoA sequestration” (Brass,
1994), can occur in metabolic disorders (Mitchell et al., 2008)
or upon exposure to xenobiotics and drugs (Brass, 1994). In
addition, CoA-esters are chemically reactive species that are
known to transacylate the cysteinyl-thiol of GSH, and glutathione
depletion has been described upon treatment of cells with certain
carboxylates (Grillo, 2011). In conclusion, the CoA-SH/CoA-
ester ratio can influence the cellular (mitochondrial) GSH/GSSG
balance. This occurs when dealing with xenobiotic carboxylates
that can neither be degraded by peroxisomal α- or β-oxidation,
nor by mitochondrial β-oxidation. As such, it is very likely that
the GSH/GSSG balance is altered in patients with fatty acid
oxidation defects.
Redox Signaling Between Peroxisomes
and Mitochondria
Over the years, it has become increasingly clear that several
cellular processes (e.g., fatty acid oxidation, antiviral signaling,
and cell fate decisions) require the proper cooperation
between mitochondria and peroxisomes (Dixit et al., 2010; Van
Veldhoven, 2010; Fransen et al., 2013; Nordgren and Fransen,
2014; Odendall et al., 2014). This is further evidenced by the
observations that both organelles share key proteins of their
division machinery (Schrader et al., 2013), and that peroxisomal
dysfunction can cause mitochondrial abnormalities (e.g.,
structural alterations of the inner mitochondrial membrane,
reduction in the activities of several RCCs, depletion of
mitochondrial DNA, increase in oxidative stress, increase in
biogenesis, etc.) (Goldfischer et al., 1973; Baes et al., 1997;
Baumgart et al., 2001; Maxwell et al., 2003; Dirkx et al., 2005;
Ferrer et al., 2005; López-Erauskin et al., 2013; Peeters et al.,
2015; Salpietro et al., 2015). Recently, it was demonstrated
that these mitochondrial perturbations closely follow the
loss of functional peroxisomes in time (Peeters et al., 2015).
However, the molecular mechanisms underlying these changes
remain poorly understood. It also remains virtually completely
unstudied to what extent mitochondrial damage contributes
to peroxisomal dysfunction. In the following subsections, we
review and discuss emerging evidence that peroxisomes and
mitochondria share an intricate redox-sensitive relationship
and cooperate in cell fate decisions. Key issues include possible
messengers, mechanisms, and physiological significance.
Peroxisomes and Mitochondria Share an
Intricate Redox-sensitive Relationship
Mitochondria and peroxisomes are central organelles in setting
cellular redox balance and homeostasis (Noctor et al., 2007;
Nordgren and Fransen, 2014). Increasing evidence now also
indicates that disturbances and/or deficiencies in peroxisomal
lipid and ROS metabolism have, directly or indirectly, an
impact on the mitochondrial redox balance (Figure 3). For
example, in cellulo experiments have shown that inhibition of
catalase activity (and hence a concomitant increase in H2O2
levels) rapidly increases mitochondrial ROS production (Koepke
et al., 2008; Ivashchenko et al., 2011; Walton and Pizzitelli,
2012). In addition, it has been observed that catalase, a non-
canonical PTS1-containing enzyme (Purdue and Lazarow, 1996),
mislocalizes to the cytosol during cellular aging (Legakis et al.,
2002) and that this phenomenon precedes the age-dependent
decrease in mitochondrial inner membrane potential (Koepke
et al., 2007). Importantly, as expression of catalase-SKL, a variant
with enhanced peroxisome targeting efficiency, can repolarize
mitochondria and reduce the number of senescent cells in late
passage cell cultures of human fibroblasts (Koepke et al., 2007),
it is reasonable to postulate that peroxisome-derived oxidative
imbalance may rapidly impair mitochondrial function (Fransen
et al., 2012; Walton and Pizzitelli, 2012). In support of this
hypothesis are, among others, the findings that (i) inactivation
of ABCD1, a peroxisomal VLCFA transporter causative for X-
linked adrenoleukodystrophy (X-ALD), causes oxidative damage
tomitochondrial proteins and impairs oxidative phosphorylation
(OXPHOS) in the spinal cord of mice (López-Erauskin et al.,
2013), (ii) acute and chronic loss of PEX5 function quickly impair
the activities of the RCCs I, III, and V in hepatocytes from
mice (Peeters et al., 2015), and (iii) the activities of the muscle
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FIGURE 3 | Peroxisomes and mitochondria share an intricate redox-sensitive relationship.
mitochondrial RCCs II, III, and IV are decreased in a Zellweger
syndrome (ZS) patient with homozygous pathogenic mutations
in the PEX16 gene (ZS is the most severe of the peroxisome
biogenesis disorders) (Salpietro et al., 2015).
Redox Messengers and Modulators
Currently, little is known about the biological messengers
that convey redox information between peroxisomes and
mitochondria. Potential messengers may include primary
ROS/RNS, ROS/RNS-modified molecules, and metabolites.
Indeed, it is well known that peroxisomes and mitochondria
are actively involved in the metabolism of H2O2, •NO, and
certain lipids that act as signaling molecules (Wang et al., 2014),
and—as such—it is very likely that alterations or disturbances
in peroxisomal or mitochondrial metabolism may trigger
communication events between these organelles. As—to our
knowledge—virtually nothing is known about how alterations
in mitochondrial activity affect peroxisome function, the next
subsections will focus on peroxisomal substrates and metabolites
that, upon changes in organelle function, may trigger changes in
mitochondrial ROS production due to metabolic stress.
Hydrogen Peroxide
As (i) peroxisomes contain copious amounts of enzymes that
can produce or degrade H2O2 (see Pro-oxidant Systems and
Antioxidant Systems), (ii) peroxisomal H2O2 can leak into the
cytosol (Mueller et al., 2002), and (iii) changes in catalase activity
(and hence in peroxisomal H2O2 metabolism) have a profound
impact on mitochondrial redox balance (see Peroxisomes and
Mitochondria Share an Intricate Redox-sensitive Relationship)
and respiration (Barbosa et al., 2013), it is plausible to suppose
that peroxisome-derived H2O2 can act as a signaling molecule
between peroxisomes and mitochondria (Camões et al., 2014).
However, the underlying physiological mechanisms are still
poorly understood, and it remains to be determined whether
peroxisomal H2O2 exerts its action on mitochondria directly
(e.g., via a RIRR response) or indirectly through the activation of
non-mitochondrial stress response pathways. In this context, it is
interesting to note that inhibition of peroxisomal catalase activity
rapidly leads to a decrease in mitochondrial aconitase activity in
early-passage human fibroblasts (Walton and Pizzitelli, 2012) and
a reduced phosphorylation of CREB1 and PGC1α transcription
in skeletal muscle cells (CREB1 is a cAMP response element
binding protein that activates the transcription of PGC1α, a
transcriptional co-activator critical for mitochondrial biogenesis
and function) (Barbosa et al., 2013).
Phytanic Acid
Phytanic acid is best known for its accumulation in Refsum’s
disease (plasma levels: ∼1.0mM; normal: <30µM), a disorder
affecting adults and that is clinically characterized by retinitis
pigmentosa, peripheral neuropathy, and cerebellar ataxia
(Wanders et al., 2011). In addition, the levels of this branched-
chain fatty acid are also elevated in patients with rhizomelic
chondrodysplasia punctata (RCDP), a more severe disease
with cerebellar atrophy caused by death of both Purkinje cells
and granular neurons (Powers et al., 1999). Interestingly, loss
of these Purkinje cells was postulated to be caused by the
incorporation of phytanic acid into cellular membranes, thereby
altering intracellular calcium levels and causing mitochondrial
dysfunction (Powers et al., 1999). In the meantime, it is known
that—when administered to rat hippocampal astrocytes—
phytanic acid (50–100µM) causes a transient rise in cytosolic
Ca2+, mitochondrial depolarization and ROS generation,
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and cell death within a few hours of exposure (Reiser et al.,
2006; Schönfeld et al., 2006). Phytanic acid (100–500µM) also
enhances the production of O•−2 in mitochondria isolated from
rat brain and heart tissue (Schönfeld et al., 2006; Grings et al.,
2012). In these tissues, such treatment also resulted in lower
mitochondrial GSH and NAD(P)H levels, a decreased membrane
potential, the oxidative modification of both lipids and proteins,
and cytochrome c release (Schönfeld et al., 2006; Grings et al.,
2012). One concern related to the studies with brain-derived
cells is that the phytanic acid concentration used might not be
physiological, given that its levels in cerebrospinal fluid are many
fold lower than in plasma (<12 nM in controls) (ten Brink et al.,
1993). In addition, it has recently been shown that phytanic acid
causes Neuro2a cell death via activation of histone deacetylase
activity (Nagai, 2015).
Pristanic Acid
Pristanic acid, the breakdown product of phytanic acid, is further
degraded in peroxisomes via β-oxidation. Hence, the plasma
level of this 2-methyl-branched fatty acid is increased in patients
lacking peroxisomes or with a deficiency in one of the involved
β-oxidation enzymes (5-80µM vs. <3µM in controls). Based
on the clinical phenotype of the latter patients, pristanic acid
seems to be linked to adult-onset sensory motor neuropathy as
well as visual (retinitis pigmentosa) and intellectual problems.
As such, many studies on the toxicity of pristanic acid focus on
neurons. Rat astrocytes, oligodendrocytes, and neurons of the
hippocampus and cerebellar granule cell layer have been reported
to generate more ROS upon exposure to pristanic acid (50–
200µM) (Rönicke et al., 2009; Busanello et al., 2014). Compared
to phytanic acid, pristanic acid has a stronger cytotoxic effect on
the hippocampal cells: it causes a more profound mitochondrial
depolarisation and induces a stronger ROS production (Rönicke
et al., 2009). However, whether or not the latter could be due
to peroxisomal oxidation was not addressed or investigated in
these studies. Note that pristanic acid apparently exerts its toxic
effect mainly through its protonophoric action, at least in human
skin fibroblasts (Komen et al., 2007). When given to post-nuclear
supernatant fractions prepared from rat brain cortex, pristanic
acid also causes ROS-generation, as evidenced by decreased
GSH levels and increased levels of MDA and protein oxidation
(Leipnitz et al., 2011; Busanello et al., 2014). In mitochondrial
preparations of rat brain, pristanic acid decreases the 19m and
NAD(P)H levels and causes mitochondrial swelling. As the latter
process can be prevented by N-acetylcysteine, swelling is most
likely caused by ROS-induced damage of the mPTP (Busanello
et al., 2012). Note that the in vitro effects of pristanic acid can
only be observed at rather high concentrations (200µM).
Polyunsaturated Fatty Acids and their Bioactive
Metabolites
Due to the lack of14-desaturase in mammals, PUFAs containing
a double bond at position 4,5 are generated via retroconversion,
a process consisting of elongation, 16-desaturation, and
one β-oxidation cycle, the latter mainly by peroxisomes.
This process ensures the formation of important PUFAs
like arachidonic (C20:4; ARA) and docosahexaenoic (C22:6;
DHA) acid. Once incorporated into membrane phospholipids,
PUFAs are main players in the generation of ROS by
a non-enzymatic process, called autooxidation. An initial
oxidative event, the formation of a hydroperoxy-derivative,
will trigger a series of reactions leading, via double bond
migration, to the generation of 4-HNE and MDA, better
known as thiobarbituric acid-reactive compounds (TBARS)
(Gardner, 1989). These lipo-oxidative end-products oxidatively
modify proteins. PUFAs are not only important phospholipid
constituents, but also the precursors of a large class of bioactive
fatty acid derivatives, called eicosanoids (derived from ARA)
or docosanoids (derived from DHA). Among the best known
are prostanoids (prostaglandins, prostacyclins, thromboxanes),
leukotrienes, and ω/ω-1-hydroxy- and epoxy-derivatives, all
being classified as signaling lipids. After inactivation, these
carboxylates are degraded via peroxisomal β-oxidation (Van
Veldhoven, 2010). PUFA-epoxides are oxidative products but,
in contrast to TBARS, they are formed enzymatically (Spector
and Kim, 2014). PUFA-epoxides are mainly inactivated by the
cytosolic EPHX2 (Morisseau and Hammock, 2013). However,
due to the presence of a weak PTS1, this enzyme is also targeted
to peroxisomes in rat (Arand et al., 1991) and in man (Luo
et al., 2008). Given that EPH2 is apparently only found in
liver and kidney peroxisomes (Enayetallah et al., 2006), these
organelles are unlikely to be important for the hydrolysis of
PUFA-epoxides. Nevertheless, the impact of peroxisomes on
PUFA levels and metabolism is not only substantial, but also
quite complex. For example, in peroxisome biogenesis disorders
and some peroxisomal β-oxidation enzyme deficiencies, brain
PUFA levels (and especially DHA) are lower (Martinez, 1992).
This decrease is seen in all cellular phospholipids, including
the mitochondrial ones (Peeters et al., 2015). Additionally, the
presence of abnormal very-long-chain PUFAs (generated via a
runaway process) has been documented in Zellweger patients
(Poulos et al., 1988) and some β-oxidation deficiencies (Infante
et al., 2002; Huyghe et al., 2006). Whether or not these PUFA-
related changes have particular consequences for ROS-signaling
or mitochondrial functioning is not known. PUFA-dependent
ROS formation in cultured cells is generally linked to stimulation
of plasmamembrane-boundNADPH-oxidase. However, in PC12
cells, PUFAs increase the fluorescence intensity of MitoSOXred,
indicating mitochondrial ROS production, likely by impairing
the electron flux in the respiratory chain (Schönfeld et al., 2011).
When given to isolated bovine heart mitochondria, ARA—like
other fatty acids—causes uncoupling via inhibition of complex I
and III (Cocco et al., 1999). Note that, under these conditions,
also more H2O2 is produced (Cocco et al., 1999).
Very-long-chain Fatty Acids
The accumulation of VLCFAs (C24:0-C30:0) is a biochemical
hallmark of X-ALD, a disorder linked to mutations in the
peroxisomal ABCD1 membrane transporter and characterized
by demyelinisation of the central nervous system. How
VLCFAs, mainly found in the cholesterylesters in white matter
and adrenals, cause neurodegeneration is not entirely clear,
but particular lipids with low abundancy are thought to
be involved. Examples include C24:0-lysophosphatidylcholine
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causing abnormal activation of microglia and apoptosis (Eichler
et al., 2008) and VLCFA-gangliosides activating CD8 cytotoxic
T-cells via aberrant binding to CD1 (Ito et al., 2001). More
recently, oxidative stress has been proposed to contribute to the
pathology. This is mainly based on the facts that (i) X-ALD
plasma has increased levels of TBARS, carbonyls, and GSSG/GSH
ratios (Vargas et al., 2004; Petrillo et al., 2013), (ii) X-ALD red
blood cells display increased GPX activity (Vargas et al., 2004),
and (iii) cultured X-ALD fibroblasts contain increased levels of
modified lysine residues (and especially N1-carboxyethyl-lysine
andN1-malondialdehyde-lysine) (Fourcade et al., 2008), elevated
catalase and SOD activities (Vargas et al., 2004), and a higher
sensitivity to L-buthionine-sulfoximine, an inhibitor of GSH
synthesis (Fourcade et al., 2008). Similarly, two-fold more O•−2
and H2O2 is produced in ABCD1 (or ACOX1)-silenced 158N
murine oligodendrocytes (Baarine et al., 2012b).
Various findings in X-ALD suggest that VLCFAs (or
related compounds) affect the mitochondrial compartment. For
example, in the dorsal root ganglia of adult X-ALD patients,
atrophic neurons were observed with lipidic inclusions in the
mitochondria (Powers et al., 2001), and abnormal mitochondria
(condensed cristae, myelinoid figures, mitochondrial dissolution)
were found in the adrenal cortical cells of (presymptomatic) 12–
13 month-old ABCD1-deficient mice (McGuinness et al., 2003).
In addition, a defective OXPHOS could be observed in ex vivo
spinal cord slices from such mice (López-Erauskin et al., 2013),
and signs of ROS (e.g., increased MDE-lysine levels) in this tissue
could already be demonstrated as early as 3.5 months of age
(Fourcade et al., 2008). At 12 months, MDE-lysine levels tended
to normalize while markers for carbonylation and glycoxidation
increased (Fourcade et al., 2008). Very recently, Reiser and
colleagues showed that VLCFAs also diminish mitochondrial
Ca2+ retention capacity, and that brain mitochondria prepared
from 6 month-old Abcd1 null mice show slightly but significantly
higher Ca2+ retention capacity than those from corresponding
wild-type mice (Kruska et al., 2015). In the context of the
OXPHOS observations, it is important to mention that the
respiratory chain is apparently normal in mitochondria isolated
from skeletal muscle tissue of 9 month-old ABCD1-deficient
mice, despite the acculumation of VLCFAs (Oezen et al., 2005).
Whether these differences in OXPHOS function represent age-
related or sample-specific variations, remains to be investigated.
However, here it is of interest to note that (i) the spinal cord is
the main X-ALD target tissue (in man) (Berger et al., 2014), (ii)
OXPHOS complexes are also severely impaired in hepatocytes
isolated from liver-specific Pex5 null mice (Peeters et al., 2015),
and (iii) isolated mitochondria and intact cells may respond
differently to an increase in VLCFAs because these lipids also
exert detrimental influence on pyridine nucleotide regeneration
in the cytosol (Kruska et al., 2015). By treatment of the Abcd1−/−
mice with a mixture of antioxidants (N-acetyl-cysteine, α-lipoic
acid, and α-tocopherol), oxidative stress, axonal degeneration,
and locomotor impairment were reversed (López-Erauskin et al.,
2011). Variable effects of VLCFAs (C24:0, C26:0) on cultured
cells have been reported. Most likely, multiple factors (e.g., the
concentration, the presence of albumin/serum, the number of
cells, and the dissolution and delivery mode of VLCFAs) do
contribute to this variation. Unfortunately, these experimental
details are rarely documented in detail. Above 20µM, C24:0,
and C26:0 appear to be toxic, and a loss of mitochondrial
potential was seen in 158N murine oligodendrocytes, rat C6
glioma cells, rat primary neuronal-glial cells, and rat primary
oligodendrocytes (Baarine et al., 2012a). This toxicity was
accompanied by an increased production of mitochondrial O•−2 ,
mitochondrial vacuolization, the destabilization of lysosomes,
and a decrease in catalase activity (Baarine et al., 2012a).
However, at physiological VLCFA concentrations (1–5µM,
levels found in X-ALD plasma), no effects were seen. Further
studies on the 158N oligodendrocytes showed that 20µM
of C24:0 or C26:0 (complexed to cyclodextrin) triggered
oxidative stress characterized by overproduction of O•−2 ,
H2O2, and •NO associated with lipid peroxidation (e.g.,
increased levels of 4-HNE, total 7-hydroxycholesterols, and total
hydroxyoctadecadienoic acids), protein carbonylation, increased
SOD2 activity, and decreased catalase activity and GSH/GSSG
ratios (Baarine et al., 2012a). Silencing of the expression of
ABCD1 or ACOX1 enhanced the effects of VLCFAs (Baarine
et al., 2012a). However, neutral lipid accumulation was only
observed with ACOX1 silencing. Human skin fibroblasts appear
to be less affected by VLCFAs. Exposure to 100µM C26:0 did
only have minor effects on the inner mitochondrial potential and
intracellular ROS production, and only SOD2 was upregulated
(Fourcade et al., 2008).
Compared to normal skin fibroblasts, X-ALD fibroblasts are
more sensitive to C26:0 in that ROS production starts at lower
concentrations (from 10µM on vs. 50µM) and GSH levels drop
more (Fourcade et al., 2008). Exposure of mouse spinal cord
slices to C26:0 (100µM) resulted in higher expression levels of
GPX1 but lower expression levels of SOD1 and SOD2. Related
to the cellular studies with VLCFAs, it should be emphasized that
C26:0 levels in plasma from healthy controls (<1.5µM, being the
sum of free and esterified C26:0) and X-ALD patients (< 5µM)
are extremely low (ten Brink et al., 1993). At physiological
VLCFA concentrations (1–5µM, levels found in X-ALD plasma),
no effects were seen in 158N murine oligodendrocytes, rat C6
glioma cells, rat primary neuronal-glial cells, and rat primary
oligodendrocytes (Baarine et al., 2012a).
Mechanisms
A hypothesis gaining prominence is that disturbances in
peroxisomal metabolism can trigger redox-related signaling
events that ultimately result in increasedmitochondrial stress and
the activation of mitochondrial stress pathways (Titorenko and
Terlecky, 2011; Beach et al., 2012; Fransen et al., 2013). However,
the communication pathways involved remain to be established.
Potential mechanisms may include (i) the diffusion of signaling
molecules from one compartment to the other via the cytosol,
(ii) the exchange of molecules via direct membrane contact sites
or vesicular transport mechanisms, and (iii) retrograde signaling.
Naturally, the communication pathway may differ depending
on the identity, reactivity, and selectivity of the messenger. For
example, as H2O2 can diffuse out of peroxisomes (see Hydrogen
Peroxide), it is very likely that this molecule can modulate
the activity of extra-peroxisomal redox-sensitive proteins (e.g.,
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transcription factors, kinases, and phosphatases) involved in
the (transcriptional) control of mitochondrial biogenesis and
function. One such example may be AKT1, a serine-threonine
protein kinase that positively regulates the activity of CREB1 [see
Hydrogen Peroxide and (Barbosa et al., 2013)] and is degraded
by the ubiquitin-mediated proteasome pathway in conditions
with elevated H2O2 (Kim et al., 2011). As the biological half-
life of some ROS is extremely short (e.g., O•−2 , ∼10
−6s; •OH,
∼10−9s), it is unlikely that these molecules will be directly
transported from one compartment to the other by diffusion
or vesicular transport mechanisms (Fransen et al., 2012; and
references therein). In this context, it is interesting to note that
we recently discovered that the production of excess O•−2 inside
peroxisomes causes cellular lipid peroxidation, and that this in
turn triggers a complex network of signaling events eventually
resulting in increased mitochondrial H2O2 production (Wang
et al., 2013b). Note that, as (i) there is some evidence that the
propagation of ROS signals from the ER to mitochondria is
facilitated by membrane contact sites (Verfaillie et al., 2012),
and (ii) such contact sites may also exist between peroxisomes
and mitochondria (Horner et al., 2011; Schrader et al., 2015),
it is possible that these sites are also involved in the redox
communication between peroxisomes andmitochondria. Finally,
as mitochondria have the ability to generate mitochondria-
derived vesicles (MDVs) that selectively transport mitochondrial
proteins to either peroxisomes or lysosomes (Neuspiel et al.,
2008; Soubannier et al., 2012a), such vesicular transport pathways
may also exist for peroxisomes. Here it is interesting to note
that, albeit the MDVs destined for the lysosomes are selectively
enriched for oxidized proteins, the functional importance of
MDV-mediated protein delivery to peroxisomes has not yet been
determined (Soubannier et al., 2012b).
Physiological Significance
Currently, it is widely accepted that mitochondrial ROS levels
are crucial to regulate the fitness of eukaryotic organisms
(Hamanaka and Chandel, 2010). In addition, it is becoming
increasingly clear thatmitochondria can act as dynamic receivers,
integrators, and transmitters of oxidative stress derived from
various sources (Nickel et al., 2014). We and others have shown
that also disturbances in peroxisomal redox metabolism have
an immediate impact on mitochondrial ROS production, both
in cellulo (Walton and Pizzitelli, 2012; Wang et al., 2013b) and
in vivo (López-Erauskin et al., 2013; Peeters et al., 2015). In
addition, there is strong evidence that defects in peroxisome
function as well as excessive ROS-production inside these
organelles can trigger mitochondria-mediated cell death (López-
Erauskin et al., 2012; Wang et al., 2013b). These and other
findings clearly demonstrate that peroxisomal andmitochondrial
fitness are closely intertwined, and—as such—it may not come
as a surprise that both organelles play a cooperative role in
the pathogenesis of at least some neurometabolic diseases. For
example, defects in peroxisome biogenesis have been reported
to lead to secondary dysfunction of mitochondria, and this
may in turn determine—at least in part—the severe phenotype
of Zellweger syndrome (Salpietro et al., 2015). The finding
that peroxisomes and mitochondria cooperatively function in
redox regulation may also offer therapeutic potential for at least
some patients with peroxisomal deficiencies. Indeed, as has been
shown in preclinical experiments with Abcd1 null mice, boosting
mitochondrial function with pioglitazone (Morató et al., 2013)
or activators of SIRT1 (Morató et al., 2015) may normalize redox
balance and prevent axonal demise.
Promises and Potential of “Omics”
Approaches
Oxidative and nitrosative stress-induced modifications are
central to a broad range of stress responses, and the accumulation
of ROS/RNS can be expected to leave traces of biomarkers at
the genome, transcriptome, proteome, and metabolome levels
(Aebersold, 2003; Ma et al., 2013). As state-of-the-art “-omics”
technologies allow detection of subtle biological variations, such
platforms offer unique opportunities for researchers to study the
molecular effects of oxidative stress at system level. The goal of
this section is to provide the reader with a few examples of how
data mining of publicly-available large-scale data may be used to
gain additional insights into potential redox signaling pathways
between peroxisomes andmitochondria (we do not intend to give
an exhaustive overview).
A first example is RedoxDB, a curated database of
experimentally-verified protein oxidative modifications (http://
biocomputer.bio.cuhk.edu.hk/RedoxDB/) (Sun et al., 2012).
Searching this database revealed that multiple peroxisomal
proteins in mammalian cells [e.g., catalase, 3-ketoacyl-CoA
thiolase (ACAA1), and hydroxyacid oxidase 2 (HAO2)]
contain cysteine thiol groups that are susceptible to oxidation
by ROS/RNS and can undergo S-nitrosylation (RSNO), S-
sulfenylation (RSOH), and/or S-thiolation (RSSG) (Doulias
et al., 2013). Note that ACAA1 catalyzes the final step in the
oxidation of straight-chain acyl-CoAs, and that HAO2 is an
FMN-dependent enzyme that oxidizes long-chain L-2-hydroxy
acids to ketoacids at the expense of O2 with concomitant
production of H2O2. The physiological relevance of these
observations remains to be determined. However, as (i) these
modifications are likely to impact enzyme activity and stability
(Stolz et al., 2002; Ortega-Galisteo et al., 2012; Gould et al.,
2013), and (ii) alterations in peroxisomal fatty acid β-oxidation
and H2O2 metabolism have been shown to affect mitochondrial
function (see Peroxisomes and Mitochondria Share an Intricate
Redox-sensitive Relationship and Redox Messengers and
Modulators), such reversible cysteine modifications may
participate in signaling processes between mitochondria and
peroxisomes.
The second example is AGEMAP (Atlas of Gene Expression in
Mouse Aging Project), a gene expression database that catalogs
changes in gene expression in mice as a function of age (Zahn
et al., 2007). The idea behind this database is that the identities
of age-related genes provide important clues about mechanisms
(e.g., stress response) that drive transcriptional changes in old age
(e.g., oxidative stress). Upon profiling the effects of aging on gene
expression in different tissues dissected frommice of ages 1, 6, 16,
and 24 months and comparing these data with DNA microarray
data on aging from human muscle, Becker and colleagues
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discovered that 17 genesets are commonly age-regulated in
multiple human and mouse tissues (Zahn et al., 2007). The most
relevant ones in the context of this manuscript are the genesets
associated with peroxisomes and the mitochondrial electron
transport chain, both of which show an overall decrease in
expression with age (for comparison, the genesets associated with
lysosomes and the inflammatory response showed a common
increasing trend in expression with age).
A third and last example concerns the proteomic analysis
of a subdomain of the ER, called the mitochondrial-associated
ER membrane (MAM). Previous confocal microscopy studies
have shown that MAM also physically connects mitochondria
to peroxisomes during antiviral response (Horner et al., 2011).
In addition, activation of the antiviral innate immune response
has been reported to alter peroxisomal and mitochondrial
morphology (Dixit et al., 2010; Horner et al., 2011). Evidence
that mitochondria and peroxisomes physically interact, can also
be inferred from proteomic datasets. Indeed, proteomic analysis
of MAM fractions isolated from mouse brain (Poston et al.,
2013), cytomegalovirus-infected human fibroblasts (Zhang et al.,
2011), and SenV- or hepatitis C virus-infected Huh7 human
hepatoma cells (Horner et al., 2015) have demonstrated that
these fractions also contain peroxisomal matrix (e.g., AGPS,
ACOX1, CAT, etc.) and membrane (e.g., ABCD1, PEX11β,
PEX14, etc.) proteins. Interestingly, some of these proteins (e.g.,
CAT and PEX14) are differentially enriched in MAM fractions
from infected and non-infected cells. Although the biological
significance of these observations remains to be established, it has
been hypothesized that the changes in expression of individual
proteins may reflect changes in organelle interactions during the
antiviral signaling response and the generation of new signaling
sites through these organelle interactions (Horner et al., 2015).
Importantly, as the MAM compartment represents a hot spot
for the intracellular signaling of important pathways, including
phospholipid synthesis and ROS generation and activity (Giorgi
et al., 2015), it is tempting to speculate that this compartment also
provides an axis through which stress stimuli and metabolites
can be transmitted from peroxisomes to mitochondria (see
Mechanisms). However, experimental evidence to support this
hypothesis is currently lacking.
Concluding Remarks
Peroxisomes and mitochondria are pivotal team players in
cellular redox metabolism. In addition, growing evidence
suggests that mitochondria can act as dynamic receivers,
integrators, and transmitters of peroxisome-derived mediators of
oxidative stress, and that alterations in the peroxisomal redox
state are likely to impact mitochondrial redox activity. Therefore,
in order to understand how a decline in peroxisome function
can be associated with cellular aging and the initiation and
progression of oxidative stress-related diseases, it is critical to
gain more insight into the molecular mechanisms by which
peroxisomes and mitochondria communicate. Future studies
should focus on (i) the link between peroxisomal/mitochondrial
(dys)function and cellular redox balance, (ii) the identification
of the proximal targets of peroxisome-derived ROS/RNS, (iii)
the molecular mechanisms underlying the redox communication
between peroxisomes and mitochondria, and (iv) the validation
of novel targets andmechanisms in primary cells and tissues from
patients and mice suffering from peroxisomal or oxidative stress-
related disorders. The outcome of such studies may open up
exciting new avenues for the community of researchers working
on cellular responses to organelle-derived oxidative stress, a
research field in which the role of peroxisomes is currently highly
underestimated and an issue of discussion.
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